Human Genome Epidemiology Literature Finder
Records 1 - 2 (of 2 Records) |
Query Trace: Alopecia and BRCA1[original query] |
---|
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial. The Lancet. Oncology 2015 Jan 16 (1): 87-97. Oza Amit M, Cibula David, Benzaquen Ana Oaknin, Poole Christopher, Mathijssen Ron H J, Sonke Gabe S, Colombo Nicoletta, Špa?ek Ji?í, Vuylsteke Peter, Hirte Holger, Mahner Sven, Plante Marie, Schmalfeldt Barbara, Mackay Helen, Rowbottom Jacqui, Lowe Elizabeth S, Dougherty Brian, Barrett J Carl, Friedlander Micha |
Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy. JNCI cancer spectrum 2020 4 4 (1): pkz085. Rugo Hope S, Ettl Johannes, Hurvitz Sara A, Gonçalves Anthony, Lee Kyung-Hun, Fehrenbacher Louis, Mina Lida A, Diab Sami, Woodward Natasha E, Yerushalmi Rinat, Goodwin Annabel, Blum Joanne L, Martin Miguel, Quek Ruben G W, Tudor Iulia Cristina, Bhattacharyya Helen, Gauthier Eric, Litton Jennifer K, Eiermann Wolfga |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: